ArticleJournal of experimental & clinical cancer research : CR2025

7aaRGD - a novel SPP1/integrin signaling-blocking peptide reverses immunosuppression and improves anti-PD-1 immunotherapy outcomes in experimental gliomas.

Aleksandra Ellert-Miklaszewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.